Educational Risk Minimisation Materials for ViiV Healthcare’s abacavir product line (Ziagen®, Trizivir®, Kivexa® andTriumeq®) -

Educational Risk Minimisation Materials for ViiV Healthcare’s abacavir product line (Ziagen®, Trizivir®, Kivexa® andTriumeq®)
Information type: Safety alerts
Source: ViiV Healthcare UK Ltd
Specialities: Infection and infectious diseases | Liver disorders
Summary
Abacavir Hypersensitivity Reaction (ABC HSR) educational programme is a global risk minimisation measure that aims to maintain low morbidity/mortality from ABC HSR and to minimise risk of ABC rechallenge in patients with clinically suspected HSR, regardless of HLA-B*5701 status.
UKMi comment
The programme also aims to increase understanding and awareness of ABC HSR by Healthcare professionals and expand on the information already included in the product labels through the provision of a website and slide deck.
Related links: Slide Deck